Bayer Co.Lab

🌟 1 more day! 🌟 Tomorrow is the Bayer Co.Lab #Berlin grand opening! Stay tuned for updates. As part of the Bayer Co.Lab network, Berlin becomes our fourth strategic location, right on the Bayer | Pharmaceuticals HQ. Alongside our Bayer Co.Lab locations in the USA, China, and Japan, this reflects our mission to promote scientific progress for patients worldwide.   If you're a #startup focused on cell and gene therapy or oncology, we invite you to join our vibrant ecosystem: https://lnkd.in/eqij68Pe #BayerCoLab #LifeSciences #Innovation #Entrepreneurship #TeamBayer

Wow, congrats to all the teams on the Sifted list! So great to see so many STATION F companies, including Aria, Kinetix, Greenly | Certified B Corp, Beev, Zenride, Sekoia.io, WhiteLab Genomics, WeWard & BuyCo :)

🌟 How It Started 🌟    Check out the early stages of Bayer Co.Lab #Berlin. Curious to see how it’s going? Stay tuned for our grand opening on November 28! 🎉   If you're a #startup focused on cell and gene therapy or #oncology, join our Bayer Co.Lab vibrant ecosystem. You will be part of a community of #entrepreneurs with opportunities to grow your company while bringing your brilliant ideas to life. (Link in the comments ⬇️). #BayerCoLab #TeamBayer

I had a great time Investival Showcase in London this week, meeting new people, connecting with old colleagues and presenting Bayer Co.Lab. Congratulations again to DISCO Pharmaceuticals GmbH on winning the prize for seed raise of the year at the European #lifestarsawards! It was an honour to present you your prize. Our brand new incubator for life science startups in Berlin is launching next week! Watch this space for more information, and reach out for collaborations. We are accepting tenancy applications, in particular in the areas of #cellandgenetherapy and/or #oncology LSX - partnering for Life Science eXecutives #BayerCoLab #innovation #startups #collaboration #CGT #biotech #lifesciences

🌟 WhiteLab Genomics Named One of France’s Top 50 Fastest-Growing Startups by Sifted! 🌟   This milestone is a direct reflection of the dedication and passion of our incredible team, as well as the trust of our clients and partners who believe in our mission to revolutionize genomic medicine. By powering our unique datasets and platform blending AI with cutting-edge biological insights, we’re pushing the boundaries of what’s possible and empowering researchers to develop breakthrough treatments that will shape the future of healthcare.  A huge thank you to everyone who has been part of our journey so far. We’re only getting started, and there’s so much more to come! Stay tuned. 🚀 #AI #genomicmedicine #growth #TechBio Y Combinator STATION F #Future40 Genopole Future4Care EIT Health Future4Care Bayer Co.Lab Omnes Debiopharm Laurent van Lerberghe Jean Pascal Tranie

We are thrilled to announce our newest Co.Lab Cambridge residency, Amplifyer Bio!   Led by the visionary Eric Huang and an exceptional team of co-founders—Maria Carmen Martin Alonso, PhD , Sangeeta Bhatia, Todd Golub, J. Christopher Love, and Viktor Adalsteinsson—Amplifyer is on a mission to revolutionize cancer diagnostics.   Their innovative approach focuses on developing novel priming agents that, when combined with current liquid biopsy diagnostics, will significantly enhance test performance. Amplifyer’s inaugural program aims to increase circulating free DNA (cfDNA) in blood, providing physicians and patients with a richer quantity and quality of genomic information related to cancer. This advancement has the potential to improve clinical outcomes and empower patients in their healthcare journey.   Join us in welcoming Amplifyer to the Bayer Co.Lab community!

Thank you to Berlin Partners for the opportunity to showcase the Boston-Cambridge ecosystem and how Bayer and Bayer Co.Lab can be the bridge between our communities.

Join us for the final hybrid presentation of the Biologic in Focus Series, "Protecting and Enforcing Biologics IP". Meghan McLean Poon, Ph.D. . and Alyssa Monsen will review how to navigate the complexities of IP law and build a litigation-ready portfolio. We encourage you to attend in-person at Bayer Co.Lab Cambridge, MA; the presentation will followed by a networking reception with great food and prizes. Space is limited,register below.  https://lnkd.in/ec-nKZbM

🌟 What an inspiring 3 days at BIO-Europe in Stockholm! 🌟 Nia Health had the privilege of joining the Startup Spotlight sponsored by Bayer Co.Lab, where we stood alongside an incredible lineup of innovative Biotech startups from across the industry. It was an honor to be chosen as one of just 8 companies presenting our technology to this great community. A special congratulations to this year’s winners, Kadence Bio and Sarcomatrix — your solutions are pushing boundaries in ways that inspire us all! The conference was a deep dive into the transformative potential of digital health, as well as the evolving landscape of drug discovery and development. It’s clear that integrating digital therapeutics with traditional pharmaceutical approaches is redefining how we address complex health needs and bring innovative solutions to patients. BIO-Europe also offered a wealth of opportunities to connect with industry leaders, investors, and like-minded innovators. Through these conversations, we gained valuable insights into the challenges and advancements in drug discovery, underscoring the importance of cross-sector collaboration to deliver impactful therapies efficiently and effectively. Thank you EBD Group for hosting, and everyone who made these days both memorable and meaningful. We look forward to what’s next and to continuing this journey of innovation together! #BIOEurope #Healthcare #DigitalHealththeratrame Harmonic Discovery Loma Therapeutics StemSight - Vision Unlimited THERAtRAME V4CURE

Are you heading to Advanced Therapies this week? Connect with our Head of Partnerships Nathan Lee PhD to learn more about how we partner and collaborate with pharma, biotech companies, academic intuitions, and others to advance genomic medicine R&D through AI.     See you there!